Difference between revisions of "Pharm Plan Agenda 2020.10.02"

From IHE Wiki
Jump to navigation Jump to search
Line 33: Line 33:
 
== Supply ==
 
== Supply ==
  
 +
This will be the main work item for the period 2020-2021
 +
FHIR resources have been proposed to HL7 ( O&O).
 +
These resources are represnting the logical model. ( this is a abstract model).
 +
This has been done for an inventory report. This could lead to a new FHIR resource.
  
  
 +
This problem has been proposed as a JIC ( joint initiative council) issue about the modelling of a product.
 +
There are different models for product. The directors will come with a proposal for the approach of this issue.
 +
 +
Esther has discussed this topic with Christian and he has introduced Marco Schwarzenbach. GDSN.
 +
This is a network to exchange product information.
  
 
== Marcom ==
 
== Marcom ==

Revision as of 06:47, 2 October 2020

Agenda

Link to Microsoft Teams
Teams

Welcome

  • Participants
    • Stephane
    • Jose
    • Leonidas


  • Review and Approve Agenda
  • Review minutes previous meetings:

https://wiki.ihe.net/index.php/Pharm_Tech_Minutes_2020.09.04

    • minutes approved and action items checked

F2F meetings

  • New dates for the new season 2020-2021?
  • Autumn F2F 22-23 October.
    • Location?
  • IHE World Summit
    • Brussels 2-6 November

Documentation Publication topics

Medication lists

Supply

This will be the main work item for the period 2020-2021 FHIR resources have been proposed to HL7 ( O&O). These resources are represnting the logical model. ( this is a abstract model). This has been done for an inventory report. This could lead to a new FHIR resource.


This problem has been proposed as a JIC ( joint initiative council) issue about the modelling of a product. There are different models for product. The directors will come with a proposal for the approach of this issue.

Esther has discussed this topic with Christian and he has introduced Marco Schwarzenbach. GDSN. This is a network to exchange product information.

Marcom

Any other business

Pharmacy Technical Committee